Hum Reprod Update:女性甲状腺激素失调对生殖影响综述:

2015-02-12 王妍允 译 MedSci原创

背景: 女性甲状腺激素失调和甲状腺过氧化物酶抗体(TPO -AB)的水平与女性低生育力和早期流产有相关影响。在这篇文章里,我们的目标是从这些大量的病例生理学的文献中提供此方面的全面概述。 方法: 该文献英文综述被完成。相关研究通过搜索Medline(联机医学文献分析与检索系统)、EMBASE(医学文摘资料库)和Cochrane Controlled Trials Regi

背景:


女性甲状腺激素失调和甲状腺过氧化物酶抗体(TPO -AB)的水平与女性低生育力和早期流产有相关影响。在这篇文章里,我们的目标是从这些大量的病例生理学的文献中提供此方面的全面概述。


方法:

该文献英文综述被完成。相关研究通过搜索Medline(联机医学文献分析与检索系统)、EMBASE(医学文摘资料库)和Cochrane Controlled Trials Register(科克伦对照试验注册)被确定。

结果:

通过文献检索到的6108篇初选文章中,挑选了105篇文章被严格得进行评价。观测数据显示改变甲状腺激素水平与干扰卵泡发育、精子发生、降低受精率和较低的胚胎质量有相关性。甲状腺素( T 3 )与FSH组合可通过PI3K / Akt通路提高颗粒细胞增殖和抑制颗粒细胞凋亡。T3被认为是刺激促性腺激素释放的在卵巢粒层细胞功能上的放大器。T3可增加子宫金属蛋白酶(MMP)、MMP-2、MMP-3、胎儿纤连蛋白、抗抑郁α5β1T3在早期胎盘绒毛外滋养细胞中的表达。甲状腺激素的转运蛋白和受体在卵巢、早期胚胎、子宫内膜、子宫和胎盘内被表达。没有其他解释这个联合的数据能够从文献中检索到。TPO抗体的存在与精子发生、受精、胚胎质量有负相关,但是在检索可能的病理生理机制上无有用的相关资料。

结论:

甲状腺激素失调和TPO抗体与干扰卵泡发育、精子发生、受精和胚胎形成都有相关性。这些联合的病理生理学仍然存在巨大的未知,这是由于证据有限,并且相关研究只拥有小样本,同时研究常常仅限于动物模型。另外也无基于TPO抗体与繁殖的联合病理生理学方面的研究。相关的证据,虽然有限,但支持甲状腺激素在生育与早孕上的作用。这证明了甲状腺素补充对患有由TPO抗体存在所导致的亚临床甲减或有患此病倾向的女性有临床干预作用。此外,需要更多的研究,以确定其基本的机制。之后妇女在接受IVF(体外受精联合胚胎移植技术,又称试管婴儿)时查明不同参数的甲状腺激素对繁殖的影响,将成为特别感兴趣的研究方向。

原始出处:

Vissenberg R1, Manders VD2, Mastenbroek S3, Fliers E4, Afink GB2, Ris-Stalpers C5, Goddijn M6, Bisschop PH4.Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction.Hum Reprod Update. 2015 Jan 28. pii: dmv004. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1796595, encodeId=e7f21e9659572, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sun Jun 21 22:33:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16686, encodeId=345c166865f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:19:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16000, encodeId=726a1600078, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:24:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15705, encodeId=894215e05f3, content=小编评论亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:48:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601730, encodeId=b2561601e301b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Feb 14 06:33:00 CST 2015, time=2015-02-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1796595, encodeId=e7f21e9659572, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sun Jun 21 22:33:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16686, encodeId=345c166865f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:19:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16000, encodeId=726a1600078, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:24:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15705, encodeId=894215e05f3, content=小编评论亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:48:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601730, encodeId=b2561601e301b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Feb 14 06:33:00 CST 2015, time=2015-02-14, status=1, ipAttribution=)]
    2015-02-22 orthoW

    不错的文章,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1796595, encodeId=e7f21e9659572, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sun Jun 21 22:33:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16686, encodeId=345c166865f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:19:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16000, encodeId=726a1600078, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:24:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15705, encodeId=894215e05f3, content=小编评论亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:48:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601730, encodeId=b2561601e301b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Feb 14 06:33:00 CST 2015, time=2015-02-14, status=1, ipAttribution=)]
    2015-02-16 Johnny1989

    谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1796595, encodeId=e7f21e9659572, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sun Jun 21 22:33:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16686, encodeId=345c166865f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:19:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16000, encodeId=726a1600078, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:24:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15705, encodeId=894215e05f3, content=小编评论亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:48:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601730, encodeId=b2561601e301b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Feb 14 06:33:00 CST 2015, time=2015-02-14, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    小编评论亮了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1796595, encodeId=e7f21e9659572, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sun Jun 21 22:33:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16686, encodeId=345c166865f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:19:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16000, encodeId=726a1600078, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:24:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15705, encodeId=894215e05f3, content=小编评论亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:48:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601730, encodeId=b2561601e301b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Feb 14 06:33:00 CST 2015, time=2015-02-14, status=1, ipAttribution=)]
    2015-02-14 sunylz

相关资讯

Int J Endocrinol:甲状腺功能看什么指标?

  Int J Endocrinol:甲状腺功能看什么指标? 评价患者的甲状腺功能看什么指标好,上海同济大学医学院的研究者们将为你解答甲状腺功能最有价值的指标,或许对你的临床实践有帮助。 研究背景及目的:甲状腺功能的正常对于维持人体正常代谢、生长发育、内环境的稳定有重要作用,血清促甲状腺激素(TSH)被认为是评价甲状腺功能最有价值的指标,FT3、FT4在血液中是起生物学作

Mol Med:美预防糖尿病性心脏病新策略

根据纽约理工学院(NYIT)骨科医学院A. Martin Gerdes教授的一项最新研究表明,患有糖尿病的大鼠,服用低剂量的甲状腺激素,可有助于恢复它们心脏的激素水平,并预防心脏功能和病理的恶化。这项研究,发表在最近的《分子医学》(Molecular Medicine)杂志,首次提供了明确的证据表明,糖尿病患者心脏组织中的低水平甲状腺激素,可能是他们患相关心脏疾病的主

Cell:挑战120年再生医学教条

人们普遍认为,出生后不久哺乳动物中的心肌细胞就停止了增殖,限制了损伤后心脏的自我修复能力。现在,来自埃默里大学医学院等机构的研究人员在《细胞》(Cell)杂志上报告称,在青春期前小鼠中的心肌细胞经历了短暂的爆发性增殖,数量上增加了 40%,使得心脏能够满足快速生长期机体的循环需求。这些研究结果表明,甲状腺激素治疗可以刺激这一过程,提高心脏病患者的心脏再生能力。论文资深作者、埃默里大学医学院 Ahs

JCEM:甲状腺激素水平与死亡率风险呈负相关

无论是临床甲状腺功能亢进和甲状腺功能减退,还是亚临床甲状腺功能亢进和甲状腺功能减退,都可导致全因死亡率和心血管死亡率增加。然而,甲状腺功能正常个体中,甲状腺激素与死亡率的关系仍不清楚。 为此,来自美国约翰霍普金斯大学彭博公共卫生学院的Guallar教授及其团队进行了一项研究,探讨正常值范围内的甲状腺激素水平与死亡率终点之间的关系。该研究结果在线发表在2014年04月07日的the Journal

ATVB:甲状腺激素与冠脉钙化具有相关性

临床和亚临床甲状腺功能减退是动脉粥样硬化的危险因素。而正常范围内的甲状腺激素水平是否也与动脉粥样硬化具有相关性尚未知,美国学者们对此进行了探讨。结果表明,在甲状腺功能正常的健康青中年队列人群中,游离甲状腺激素和促甲状腺激素正常水平低值与亚临床冠状动脉疾病发生率较高以及与冠状动脉钙化(CAC)水平较高具有相关性。论文7月24日在线发表于《动脉粥样硬化、血栓形成和血管生物学》(Atherosclero

Thyroid:健康成年人甲状腺激素水平与心血管危险因素有关

先前发现甲状腺功能在正常范围的健康青年男性身体组成欠佳与较高的FT3水平有关。另外,较高的FT3/FT4比值与孕妇较差的代谢表型和胎盘过度生长有关。为了探讨甲状腺功能正常的健康中年男性和女性人群中,血清TSH、甲状腺激素水平和FT3/FT4比值是否与代谢和肥胖相关心血管风险指标有关,来自比利时根特大学Greet Leen Roef教授及其团队进行了一项研究,该研究发现在甲状腺功能正常的健康中年男性